Clinical Research Investigator-Initiated Awards support investigators conducting clinical studies of Crohn’s disease and ulcerative colitis to improve patient care and change clinical practice.
Funder: Crohn's and Colitis Foundation
Due Dates: December 1, 2026 (Pre-application) | January 28, 2027 (Invited full proposal)
Funding Amounts: Up to $250,000 per year in total costs for up to three years
Summary: Supports investigator-initiated clinical research addressing important IBD questions to directly improve patient care and clinical practice.
Key Information: Patients and/or caregivers must join the research team and provide a research-feasibility letter.
The Crohn's and Colitis Foundation’s Clinical Research Investigator-Initiated Awards (CRIA) support clinical studies of Crohn’s disease and ulcerative colitis through Career Development Awards and Senior Research Awards. Eligible approaches include clinical trials, actively enrolling registries or cohorts, health services research, epidemiology, comparative effectiveness research, and studies using large claims or administrative databases.
The program prioritizes pragmatic clinical research that can change prevailing practice. Priority topics include IBD incidence and prevalence, particularly minority health; medication positioning; therapeutic drug monitoring; pain management; and healthcare economics and resource utilization, particularly multidisciplinary care. Other topics require a compelling clinical rationale. Expected outcomes include highly cited publications, citations in clinical guidelines, or follow-on funding. Studies primarily collecting biosamples or developing predictive markers are considered translational research and fall outside this program.